marker: be used to move ahead 3 square

from ConceptNet
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents substance
Weight: 0.57
, material
Weight: 0.56
, device
Weight: 0.55
, time
Weight: 0.55
Siblings high blood pressure
Weight: 0.66
, blood
Weight: 0.60
, pen
Weight: 0.57
, tattoo
Weight: 0.55
, sharpie
Weight: 0.54

Related properties

Property Similarity
be used to move ahead 3 square 1.00
move forward 0.76
move and stand still 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.44
Rule weight: 0.66
Evidence weight: 0.88
Similarity weight: 0.76
Evidence: 0.87
Plausible(time, move forward)
Evidence: 0.94
¬ Typical(marker, be used to move ahead 3 square)
0.16
Rule weight: 0.66
Evidence weight: 0.31
Similarity weight: 0.75
Evidence: 0.27
Plausible(time, move and stand still)
Evidence: 0.94
¬ Typical(marker, be used to move ahead 3 square)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.86
Similarity weight: 0.75
Evidence: 0.46
Plausible(marker, be used to move ahead 3 square)
Evidence: 0.27
¬ Plausible(time, move and stand still)
0.04
Rule weight: 0.09
Evidence weight: 0.53
Similarity weight: 0.76
Evidence: 0.46
Plausible(marker, be used to move ahead 3 square)
Evidence: 0.87
¬ Plausible(time, move forward)

Remarkability exclusitivity betweem a parent and a child

0.42
Rule weight: 0.58
Evidence weight: 0.97
Similarity weight: 0.75
Evidence: 0.11
¬ Remarkable(marker, be used to move ahead 3 square)
Evidence: 0.28
¬ Remarkable(time, move and stand still)
0.42
Rule weight: 0.58
Evidence weight: 0.96
Similarity weight: 0.76
Evidence: 0.11
¬ Remarkable(marker, be used to move ahead 3 square)
Evidence: 0.40
¬ Remarkable(time, move forward)

Remarkability from parent implausibility

0.30
Rule weight: 0.42
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.87
Plausible(time, move forward)
Evidence: 0.11
Remarkable(marker, be used to move ahead 3 square)
Evidence: 0.46
¬ Plausible(marker, be used to move ahead 3 square)
0.22
Rule weight: 0.42
Evidence weight: 0.70
Similarity weight: 0.75
Evidence: 0.27
Plausible(time, move and stand still)
Evidence: 0.11
Remarkable(marker, be used to move ahead 3 square)
Evidence: 0.46
¬ Plausible(marker, be used to move ahead 3 square)

Salient implies Plausible

0.27
Rule weight: 0.28
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.46
Plausible(marker, be used to move ahead 3 square)
Evidence: 0.07
¬ Salient(marker, be used to move ahead 3 square)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.07
Salient(marker, be used to move ahead 3 square)
Evidence: 0.94
¬ Typical(marker, be used to move ahead 3 square)
Evidence: 0.11
¬ Remarkable(marker, be used to move ahead 3 square)

Typical implies Plausible

0.24
Rule weight: 0.48
Evidence weight: 0.50
Similarity weight: 1.00
Evidence: 0.46
Plausible(marker, be used to move ahead 3 square)
Evidence: 0.94
¬ Typical(marker, be used to move ahead 3 square)

Typicality and Rermarkability incompatibility between a parent and a child

0.37
Rule weight: 0.51
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.11
¬ Remarkable(marker, be used to move ahead 3 square)
Evidence: 0.30
¬ Typical(time, move forward)
0.36
Rule weight: 0.51
Evidence weight: 0.95
Similarity weight: 0.75
Evidence: 0.11
¬ Remarkable(marker, be used to move ahead 3 square)
Evidence: 0.49
¬ Typical(time, move and stand still)

Typicality inheritance from parent to child

0.36
Rule weight: 0.48
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.94
Typical(marker, be used to move ahead 3 square)
Evidence: 0.30
¬ Typical(time, move forward)
0.35
Rule weight: 0.48
Evidence weight: 0.97
Similarity weight: 0.75
Evidence: 0.94
Typical(marker, be used to move ahead 3 square)
Evidence: 0.49
¬ Typical(time, move and stand still)